| |
|
|
|
Harvard Bioscience  
|
|
5.75 0.05 (0.01%) |
04-20 16:00 |
|
Open: |
5.7 |
Pre close: |
5.7 |
Target:
|
7.07
|
|
High: |
5.8 |
Low: |
5.65 |
Resistance:
|
6.05
7.07
|
|
Volume: |
86,192 |
Market Cap: |
205M |
Support:
|
4.91
4.20
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
5.81
 |
MACD |
MACD(12,26):
|
0.28  |
|
MA(20): |
5.32 |
Signal(12,26,9): |
0.24 |
|
MA(100): |
4.33 |
Stochastic Oscillator |
%K(14,3):
|
77.33 |
|
MA(250): |
3.49 |
%D(3): |
81.72 |
|
Average Volume(K) |
3-Month: |
15243
|
52-Week |
High:
|
6.05 |
|
10-Days: |
16461 |
Low: |
2.30 |
|
RSI |
RSI(14):
|
66.89 |
Change(%): |
130.0 |
|
Financials, Statistics and Valuation |
|
EPS |
0.060 |
Return on Equity (ttm) |
-1.1 |
Shares Out. (M) |
35.66 |
|
EPS Est. Current Year |
0.130 |
Return on Assets (ttm) |
-0.8 |
Shares Float (M) |
28.04 |
|
EPS Est. Next Year |
0.170 |
PEG Ratio |
2.45 |
% Held by Insiders |
21.90 |
|
EPS Est. Next Quarter |
0.040 |
Qtrly Rev. Growth |
4.0 |
% Held by Institutions |
61.20 |
|
Forward EPS |
0.260 |
Gross Profit (p.s.) |
0.965 |
Shares Short (K) |
238 |
|
Book Value (p.s.) |
2.470 |
EBITDA (p.s.) |
0.043 |
P/E |
95.83 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.33 |
|
Profit Margin |
0.26 |
Operating Cash Flow
(M) |
1.06 |
P/S |
69843856.00 |
|
Operating Margin |
-0.10 |
Levered Free Cash Flow
(M) |
3.07 |
P/CF |
193.46 |
|
|
|
|
|
|
